Hydroxycarbamide reduces mortality in adults with sickle cell anaemia

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1382, 2003-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydroxycarbamide well tolerated in paediatric sickle cell anaemia

By  

Inpharma, Vol. 1, Iss. 1326, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Hydroxycarbamide holds up to long-term scrutiny in sickle cell anaemia

By  

Inpharma, Vol. 1, Iss. 1275, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Cellular and Molecular Effects of Hydroxycarbamide in Sickle Cell Patients

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 2, 2014-01 ,pp. : 114-122

Bentham Science Publishers

Access to resources Recommend Favorite

Sickle Cell Anaemia: Epidemiology and Cost of Illness

By Nietert P.J.  

PharmacoEconomics, Vol. 20, Iss. 6, 2002-06 ,pp. : 357-366

Adis International

Access to resources Recommend Favorite

Stroke in Children With Sickle Cell Anaemia: Aetiology and Treatment

By Pegelow C.H.  

Pediatric Drugs, Vol. 3, Iss. 6, 2001-01 ,pp. : 421-432

Adis International

Access to resources Recommend Favorite